France’s slow vaccine rollout won’t prevent recovery

France’s tight restrictions are set to be in place for at least another month or two, so GDP will not recover strongly during Q1. However, although the slow start to the vaccine rollout poses a downside risk for 2021, we think the pace will pick up enough to allow most measures to be lifted in Q2.

Subscriber content

Read this in full, free

Start a free trial and use one of your 10 free starter credits to unlock this piece.


Free. 10 articles. No card required.
By completing this form you are agreeing to our Terms and Conditions for the provision of a free trial of Capital Economics' services. We take your privacy seriously and will not share your details with others without your consent. By providing your details, including your email address, you are consenting to Capital Economics sending you macroeconomic commentary and analysis. You can unsubscribe at any time. See our Privacy Policy for more information.

Already a client or trialist? Log in to read this.